rs140505250
Positions:
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_004312.3(ARR3):āc.1052C>Gā(p.Pro351Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00177 in 1,209,147 control chromosomes in the GnomAD database, including 1 homozygotes. There are 690 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: š 0.0017 ( 0 hom., 51 hem., cov: 21)
Exomes š: 0.0018 ( 1 hom. 639 hem. )
Consequence
ARR3
NM_004312.3 missense
NM_004312.3 missense
Scores
6
2
9
Clinical Significance
Conservation
PhyloP100: 6.82
Genes affected
ARR3 (HGNC:710): (arrestin 3) The protein encoded by this gene is a non-visual arrestin which binds to agonist-activated, phosphorylated G protein-coupled receptors. This binding uncouples the receptor from the heterotrimeric G protein, resulting in termination of the G protein-coupled receptor signaling. The encoded protein also is a part of the centrosome, interacting with gamma-tubulin to help regulate proper centrosome function. [provided by RefSeq, May 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.14858988).
BP6
Variant X-70280804-C-G is Benign according to our data. Variant chrX-70280804-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 3352517.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High Hemizygotes in GnomAd4 at 51 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARR3 | NM_004312.3 | c.1052C>G | p.Pro351Arg | missense_variant | 15/17 | ENST00000307959.9 | NP_004303.2 | |
ARR3 | XM_047442105.1 | c.1076C>G | p.Pro359Arg | missense_variant | 14/16 | XP_047298061.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARR3 | ENST00000307959.9 | c.1052C>G | p.Pro351Arg | missense_variant | 15/17 | 1 | NM_004312.3 | ENSP00000311538.8 | ||
ARR3 | ENST00000374495.7 | c.1052C>G | p.Pro351Arg | missense_variant | 15/16 | 1 | ENSP00000363619.3 |
Frequencies
GnomAD3 genomes AF: 0.00174 AC: 193AN: 110960Hom.: 0 Cov.: 21 AF XY: 0.00154 AC XY: 51AN XY: 33162
GnomAD3 genomes
AF:
AC:
193
AN:
110960
Hom.:
Cov.:
21
AF XY:
AC XY:
51
AN XY:
33162
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00158 AC: 290AN: 183385Hom.: 0 AF XY: 0.00144 AC XY: 98AN XY: 67821
GnomAD3 exomes
AF:
AC:
290
AN:
183385
Hom.:
AF XY:
AC XY:
98
AN XY:
67821
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00178 AC: 1953AN: 1098133Hom.: 1 Cov.: 32 AF XY: 0.00176 AC XY: 639AN XY: 363519
GnomAD4 exome
AF:
AC:
1953
AN:
1098133
Hom.:
Cov.:
32
AF XY:
AC XY:
639
AN XY:
363519
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00174 AC: 193AN: 111014Hom.: 0 Cov.: 21 AF XY: 0.00153 AC XY: 51AN XY: 33226
GnomAD4 genome
AF:
AC:
193
AN:
111014
Hom.:
Cov.:
21
AF XY:
AC XY:
51
AN XY:
33226
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
6
ALSPAC
AF:
AC:
6
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
17
ExAC
AF:
AC:
212
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
ARR3-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 22, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;.;T
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;.;M
PrimateAI
Benign
T
PROVEAN
Pathogenic
D;.;D
REVEL
Pathogenic
Sift
Pathogenic
D;.;D
Sift4G
Pathogenic
D;D;D
Polyphen
D;.;D
Vest4
MVP
MPC
0.44
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at